candida (lactis-condensi/ robusta/utilis)/ debaryomyces/lactobacillus/leuconostoc/pichia/saccharomyces/streptococcus (cremoris/faecalis/lactis/thermophilus)/ torulaspora delbrueckii/zygosaccharomyces ferment extract est-il sûr pendant la grossesse ?

Related ingredients

Frequently asked questions

candida (lactis-condensi/ robusta/utilis)/ debaryomyces/lactobacillus/leuconostoc/pichia/saccharomyces/streptococcus (cremoris/faecalis/lactis/thermophilus)/ torulaspora delbrueckii/zygosaccharomyces ferment extract est-il sûr pendant la grossesse ?

No harmonised CLP reproductive classifications (ECHA Annex VI) or SCCS/CIR reproductive contraindications were identified for microbial/yeast ferment extracts of the listed species; peer‑reviewed literature does not indicate teratogenicity or reproductive toxicity for topical use of such ferments. Cosmetic safety databases (CosIng/EWG) commonly list these as ferment extracts without reproduction flags, consistent with CIR precedent that cosmetic ferments are 'safe as used' when appropriately processed.

candida (lactis-condensi/ robusta/utilis)/ debaryomyces/lactobacillus/leuconostoc/pichia/saccharomyces/streptococcus (cremoris/faecalis/lactis/thermophilus)/ torulaspora delbrueckii/zygosaccharomyces ferment extract est-il sûr pendant l'allaitement ?

No evidence from regulatory sources or peer‑reviewed studies suggests systemic reproductive toxicity or secretion into breast milk from topical application of these microbial ferment extracts; no harmonised classifications or SCCS/CIR warnings were found.

candida (lactis-condensi/ robusta/utilis)/ debaryomyces/lactobacillus/leuconostoc/pichia/saccharomyces/streptococcus (cremoris/faecalis/lactis/thermophilus)/ torulaspora delbrueckii/zygosaccharomyces ferment extract est-il sûr pour la peau de bébé ?

Hazard and mechanism: no infant‑specific reproductive or developmental effects located. Exposure: dermal absorption from topical ferments is expected to be negligible in adults, but per guidance infant exposure scoring is increased by +1 due to higher surface‑area‑to‑weight and immature barrier, so exposure is assigned 1 for 0–3 yr skin even though systemic absorption is still expected to be low. Note: potential for topical sensitization or infection in severely immunocompromised infants is a general consideration but not a reproductive/developmental finding.

Comment VeriMom évalue-t-il candida (lactis-condensi/ robusta/utilis)/ debaryomyces/lactobacillus/leuconostoc/pichia/saccharomyces/streptococcus (cremoris/faecalis/lactis/thermophilus)/ torulaspora delbrueckii/zygosaccharomyces ferment extract ?

VeriMom évalue candida (lactis-condensi/ robusta/utilis)/ debaryomyces/lactobacillus/leuconostoc/pichia/saccharomyces/streptococcus (cremoris/faecalis/lactis/thermophilus)/ torulaspora delbrueckii/zygosaccharomyces ferment extract à 100/100 (pas de risques connus) sur la base du statut EU CosIng, des classifications ECHA et des études PubMed.

Quelles sont les alternatives sûres à candida (lactis-condensi/ robusta/utilis)/ debaryomyces/lactobacillus/leuconostoc/pichia/saccharomyces/streptococcus (cremoris/faecalis/lactis/thermophilus)/ torulaspora delbrueckii/zygosaccharomyces ferment extract pendant la grossesse ?

Consultez notre liste d'alternatives sûres à candida (lactis-condensi/ robusta/utilis)/ debaryomyces/lactobacillus/leuconostoc/pichia/saccharomyces/streptococcus (cremoris/faecalis/lactis/thermophilus)/ torulaspora delbrueckii/zygosaccharomyces ferment extract basée sur une fonction similaire et une classification sans risques connus.